PROCEPT BioRobotics (PRCT) Change in Receivables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Change in Receivables for 7 consecutive years, with $11.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Receivables rose 329.82% year-over-year to $11.6 million in Q2 2026; TTM through Jun 2026 was $27.1 million, a 11.87% increase from a year earlier, with the FY2025 full-year figure at $898000.0, down 97.5% from the prior year.
• Change in Receivables was $11.6 million for Q2 2026 at PROCEPT BioRobotics, down from $13.3 million in the prior quarter.
• Over five years, Change in Receivables peaked at $14.8 million in Q4 2024 and troughed at -$3.9 million in Q1 2025.
• A 5-year average of $5.9 million and a median of $4.1 million in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables surged 631.15% in 2024 and slumped 150.99% in 2025, its largest moves.
• Over 5 years, Change in Receivables stood at $2.4 million in 2022, then surged by 465.08% to $13.8 million in 2023, then rose by 7.84% to $14.8 million in 2024, then tumbled by 115.04% to -$2.2 million in 2025, then surged by 621.57% to $11.6 million in 2026.
• The last three Change in Receivables figures came in at $11.6 million (Q2 2026), $13.3 million (Q1 2026), and -$2.2 million (Q4 2025), per Business Quant data.